[go: up one dir, main page]

FR2390959A1 - Association therapeutique a visee anti-agregante et regularisatrice de la duree de vie plaquettaire a base de pyrimido-pyrimidine et d'acide acetyl salycilique - Google Patents

Association therapeutique a visee anti-agregante et regularisatrice de la duree de vie plaquettaire a base de pyrimido-pyrimidine et d'acide acetyl salycilique

Info

Publication number
FR2390959A1
FR2390959A1 FR7814338A FR7814338A FR2390959A1 FR 2390959 A1 FR2390959 A1 FR 2390959A1 FR 7814338 A FR7814338 A FR 7814338A FR 7814338 A FR7814338 A FR 7814338A FR 2390959 A1 FR2390959 A1 FR 2390959A1
Authority
FR
France
Prior art keywords
compsns
useful
pyrimido
aspirin
pyrimidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7814338A
Other languages
English (en)
Other versions
FR2390959B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PRUGNAUD ROBERT
Original Assignee
PRUGNAUD ROBERT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PRUGNAUD ROBERT filed Critical PRUGNAUD ROBERT
Publication of FR2390959A1 publication Critical patent/FR2390959A1/fr
Application granted granted Critical
Publication of FR2390959B1 publication Critical patent/FR2390959B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention est relative à une nouvelle composition pharmaceutique à base de dérivés de la pyrimido-pyrimidine et d'acide acétyl salicylique. Cette composition contient au moins un composé de formule :
FR7814338A 1977-05-16 1978-05-12 Association therapeutique a visee anti-agregante et regularisatrice de la duree de vie plaquettaire a base de pyrimido-pyrimidine et d'acide acetyl salycilique Granted FR2390959A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU77353A LU77353A1 (fr) 1977-05-16 1977-05-16

Publications (2)

Publication Number Publication Date
FR2390959A1 true FR2390959A1 (fr) 1978-12-15
FR2390959B1 FR2390959B1 (fr) 1983-03-25

Family

ID=19728580

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7814338A Granted FR2390959A1 (fr) 1977-05-16 1978-05-12 Association therapeutique a visee anti-agregante et regularisatrice de la duree de vie plaquettaire a base de pyrimido-pyrimidine et d'acide acetyl salycilique

Country Status (2)

Country Link
FR (1) FR2390959A1 (fr)
LU (1) LU77353A1 (fr)

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2452923A2 (fr) * 1979-04-02 1980-10-31 Panoz Donald Nouvelle forme galenique d'administration de medicaments par voie orale, a liberation programmee
FR2452922A2 (fr) * 1979-04-02 1980-10-31 Panoz Donald Nouvelle forme galenique d'administration de medicaments par voie orale, a liberation programmee
FR2453642A1 (fr) * 1979-04-12 1980-11-07 Sanofi Sa Compositions therapeutiques a usage oral et a liberation programmee du methanesulfonate de dihydroergotoxine
FR2454804A1 (fr) * 1979-04-26 1980-11-21 Sanofi Sa Medicament a base de dihydroergotoxine et son procede de preparation
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
FR2470600A2 (fr) * 1979-12-07 1981-06-12 Panoz Donald Nouvelle forme galenique d'administration de medicaments par voie orale, a liberation programmee
WO1982001468A1 (fr) * 1980-10-28 1982-05-13 Claude Laruelle Nouvelle forme galenique d'administration du metoclopramide, son procede de preparation et medicament comprenant cette nouvelle forme
EP0052075A1 (fr) * 1980-11-12 1982-05-19 Ciba-Geigy Ag Granule pharmaceutique à action retardée
FR2494112A1 (fr) * 1980-11-19 1982-05-21 Laruelle Claude
US4367217A (en) 1980-01-12 1983-01-04 Boehringer Ingelheim Gmbh Dipyricamole sustained release forms comprising lacquer-coated particles and the preparation thereof
FR2513118A1 (fr) * 1981-09-18 1983-03-25 Rocador Sa Composition pharmaceutique a base de dipyridamol et de sel d'aluminium de l'acide acetylsalicylique pour combattre l'agregation plaquettaire
EP0068191A3 (en) * 1981-06-19 1983-08-10 Dr. Karl Thomae Gmbh Oral forms of dipyridamole
US4444777A (en) * 1981-07-30 1984-04-24 Bristol-Myers Company Pharmaceutical compositions of anagrelide and sulfinpyrazone
FR2539995A1 (fr) * 1983-01-28 1984-08-03 Sanofi Sa Medicament a liberation programmee a base d'acide acetylsalicylique
EP0169465A3 (en) * 1984-07-21 1986-05-28 Hoechst Aktiengesellschaft Mixture of pyrimido-pyrimidines and o-acetyl-salicylic acid, or their pharmacologically acceptable salts, and its use
US4609542A (en) * 1978-12-22 1986-09-02 Elan Corporation, P.L.C. New pharmaceutical forms for administration of medicaments by oral route, with programmed release
EP0257344A1 (fr) * 1986-08-13 1988-03-02 Dr. Karl Thomae GmbH Médicaments contenant du dipyridamol ou mopidamol et de l'acide O-acétylsalicylique ou ses sels compatibles physiologiquement, procédé pour leur préparation et leur application pour combattre la formation de thrombus
WO1991004031A1 (fr) * 1989-09-18 1991-04-04 The Du Pont Merck Pharmaceutical Company Composition faiblement dosee d'anticoagulant oral/anti-agregants plaquettaires
AT393962B (de) * 1987-10-22 1992-01-10 Thomae Gmbh Dr K Synergistische arzneimittelkombination mit einem gehalt an einem phosphodiesterase-hemmer und derenverwendung
FR2681596A1 (fr) * 1991-09-23 1993-03-26 Thomas Andre Procede de preparation d'acetylsalicylates des bases puriques et pyrimidiques et de leurs nucleosides.
WO2010036975A3 (fr) * 2008-09-25 2010-08-12 Teva Pharmaceutical Industries Ltd. Formulations de dipyridamole et d'acide acétylsalicylique et leur procédé de préparation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NV2030/77 *

Cited By (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4726951A (en) * 1978-12-22 1988-02-23 Elan Corporation P.L.C. New pharmaceutical forms for administration of medicaments by oral route, with programmed release
US4609542A (en) * 1978-12-22 1986-09-02 Elan Corporation, P.L.C. New pharmaceutical forms for administration of medicaments by oral route, with programmed release
FR2452922A2 (fr) * 1979-04-02 1980-10-31 Panoz Donald Nouvelle forme galenique d'administration de medicaments par voie orale, a liberation programmee
FR2452923A2 (fr) * 1979-04-02 1980-10-31 Panoz Donald Nouvelle forme galenique d'administration de medicaments par voie orale, a liberation programmee
FR2453642A1 (fr) * 1979-04-12 1980-11-07 Sanofi Sa Compositions therapeutiques a usage oral et a liberation programmee du methanesulfonate de dihydroergotoxine
FR2454804A1 (fr) * 1979-04-26 1980-11-21 Sanofi Sa Medicament a base de dihydroergotoxine et son procede de preparation
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
FR2470600A2 (fr) * 1979-12-07 1981-06-12 Panoz Donald Nouvelle forme galenique d'administration de medicaments par voie orale, a liberation programmee
WO1981001652A1 (fr) * 1979-12-07 1981-06-25 D Panoz Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenues
US5051262A (en) * 1979-12-07 1991-09-24 Elan Corp., P.L.C. Processes for the preparation of delayed action and programmed release pharmaceutical forms and medicaments obtained thereby
US4367217A (en) 1980-01-12 1983-01-04 Boehringer Ingelheim Gmbh Dipyricamole sustained release forms comprising lacquer-coated particles and the preparation thereof
EP0032562B1 (fr) * 1980-01-12 1984-03-14 Dr. Karl Thomae GmbH Formes-retard pour l'administration du dipyridamol et procédés pour leur préparation
WO1982001468A1 (fr) * 1980-10-28 1982-05-13 Claude Laruelle Nouvelle forme galenique d'administration du metoclopramide, son procede de preparation et medicament comprenant cette nouvelle forme
JPS57502121A (fr) * 1980-10-28 1982-12-02
EP0052075A1 (fr) * 1980-11-12 1982-05-19 Ciba-Geigy Ag Granule pharmaceutique à action retardée
FR2494112A1 (fr) * 1980-11-19 1982-05-21 Laruelle Claude
WO1982001649A1 (fr) * 1980-11-19 1982-05-27 Laruelle Claude Nouvelle forme galenique du fenofibrate, son procede d'obtention, son application comme medicament
EP0068191A3 (en) * 1981-06-19 1983-08-10 Dr. Karl Thomae Gmbh Oral forms of dipyridamole
US4444777A (en) * 1981-07-30 1984-04-24 Bristol-Myers Company Pharmaceutical compositions of anagrelide and sulfinpyrazone
FR2513118A1 (fr) * 1981-09-18 1983-03-25 Rocador Sa Composition pharmaceutique a base de dipyridamol et de sel d'aluminium de l'acide acetylsalicylique pour combattre l'agregation plaquettaire
FR2539995A1 (fr) * 1983-01-28 1984-08-03 Sanofi Sa Medicament a liberation programmee a base d'acide acetylsalicylique
EP0115976A1 (fr) * 1983-01-28 1984-08-15 Elf Sanofi Médicament à libération programmée à base d'acide acétylsalicylique
EP0169465A3 (en) * 1984-07-21 1986-05-28 Hoechst Aktiengesellschaft Mixture of pyrimido-pyrimidines and o-acetyl-salicylic acid, or their pharmacologically acceptable salts, and its use
EP0257344A1 (fr) * 1986-08-13 1988-03-02 Dr. Karl Thomae GmbH Médicaments contenant du dipyridamol ou mopidamol et de l'acide O-acétylsalicylique ou ses sels compatibles physiologiquement, procédé pour leur préparation et leur application pour combattre la formation de thrombus
US6015577A (en) * 1986-08-13 2000-01-18 Dr. Karl Thomae GmbH Pharmaceutical compositions containing dipyridamole or mopidamol and acetylsalicylic acid or the physiologically acceptable salts thereof, processes for preparing them and their use in treating clot formation
AT393962B (de) * 1987-10-22 1992-01-10 Thomae Gmbh Dr K Synergistische arzneimittelkombination mit einem gehalt an einem phosphodiesterase-hemmer und derenverwendung
WO1991004031A1 (fr) * 1989-09-18 1991-04-04 The Du Pont Merck Pharmaceutical Company Composition faiblement dosee d'anticoagulant oral/anti-agregants plaquettaires
US5041430A (en) * 1989-09-18 1991-08-20 Du Pont Mereck Pharmaceutical Company Oral anticoagulant/platelet inhibitor low dose formulation
GR900100702A (en) * 1989-09-18 1992-01-20 Du Pont Low dosage oral antithrombotic composition
FR2681596A1 (fr) * 1991-09-23 1993-03-26 Thomas Andre Procede de preparation d'acetylsalicylates des bases puriques et pyrimidiques et de leurs nucleosides.
WO2010036975A3 (fr) * 2008-09-25 2010-08-12 Teva Pharmaceutical Industries Ltd. Formulations de dipyridamole et d'acide acétylsalicylique et leur procédé de préparation

Also Published As

Publication number Publication date
LU77353A1 (fr) 1979-01-19
FR2390959B1 (fr) 1983-03-25

Similar Documents

Publication Publication Date Title
FR2390959A1 (fr) Association therapeutique a visee anti-agregante et regularisatrice de la duree de vie plaquettaire a base de pyrimido-pyrimidine et d'acide acetyl salycilique
FR2329261A1 (fr) Corps d'insertion oculaire pour le traitement de la siccite oculaire par deficience aqueuse
AR248140A1 (es) Composicion de 1, 4, 7, 10-tetraazaciclododecano como la fraccion macrolitica, o sales fisiologicamente aceptables del mismo y radionuclidos como agente terapeuticamente activo.
IE870194L (en) Use of lithium compounds in senile dementia
OA08581A (en) Treatment of diseases caused by retroviruses.
DE69523350D1 (de) Behandlung von hyperproliferativen Gefässerkrankungen
EP0259485A4 (fr) Sels de metaux lourds de l'acide hyaluronique utiles en tant qu'agents antimicrobiens.
EP0285008A3 (en) The use of buspirone for preparing a pharmaceutical composition for the treatment of alcohol abuse
DK154208C (da) Analogifremgangsmaade til fremstilling af p-substituerede 3-fenoxy-1-alkylaminopropanoler eller terapeutisk acceptable salte deraf
DK644388D0 (da) Farmaceutiske praeparater indeholdende 3-hydroxy-smoeresyrederivater
ES470458A1 (es) Procedimiento para la obtencion de sales de 1-(2-feniletil) triazolio de efecto fungicida
ATE109350T1 (de) Verwendung von ofloxacin oder dessen salzen zur herstellung eines lokalpräparats für die behandlung von otopathie.
ATE84716T1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelialgewebekrankheiten.
SE7705370L (sv) 12-azaprostanoinsyror
ES8706692A1 (es) Un metodo para preparar nuevos derivados de cefem
FI871304A0 (fi) Menetelmä nootrooppisen vaikutuksen omaavien aminohappojohdannaisten valmistamiseksi
HUT51295A (en) Process for producing peptidalcohol derivatives of anticoagulant activity
ATE206053T1 (de) Verwendung von monosialogangliosid gml oder von n-dichlor-acetyl-lyso-gml zur vorbeugung oder zur umkehrung der von einer langzeitbehandlung mit l- dopa bei der therapie von morbus parkinson induzierten neuronale degeneration
ATE162717T1 (de) Behandlung kardialer dysfunktion mit 15- ketoprostaglandinderivaten
IT1173577B (it) Procedimento per il trattamento di articoli di maglieria
ES2036533T3 (es) Derivados de 1,6-naftiridina, procedimientos para su obtencion y de medicamentos que los contienen para el tratamiento de enfermedades de los vasos sanguineos.
PT85866A (en) Process for the preparation of therapeutic agents for the treatment of peptic ulcers containing 1,2,3,6-tetrahydro-3-methyl-1-(5-oxohexyl)-7-propyl-purine,6-dione and their derivatives
EP0075823A3 (en) Use of basically substituted phenylacetonitriles in the prophylactic treatment of illnesses, and agents therefor
FR2622443B1 (fr) Agent contenant un compose organogermanium pour ameliorer les fonctions des organes reduites par une inhibition de la circulation du sang
GR75239B (fr)

Legal Events

Date Code Title Description
ST Notification of lapse